未找到相关数据
血小板生成因子的研究进展
被引：9
作者：
欧瑞明
钟雪云
陈运贤
机构：
[1] 中山医科大学附属第一医院血液内科,暨南大学医学院病理解剖教研室,中山医科大学附属第一医院血液内科广东广州,广东广州,广东广州
来源：
关键词：
血小板生成素;
白细胞介素类;
血小板减少;
D O I：
暂无
中图分类号：
R965 [实验药理学];
学科分类号：
摘要：
Currently, platelet transfusion is the primary treatment for thrombocytopnia which results from intensive chemotherapy and radiotherapy of cancer. While repeated platelet transfusions are associated with several problems. The clinical availability of safe and effective platelet growth factors is eagerly awaited. Currently, a mumber of hematopoietic growth factors with thrombopoietic activity have been identified. This review discusses the biological characteristics and the clinical trial investigation development of platelet growth factors.
引用
收藏
页码：94 / 97
页数：4
相关论文